Strength of Donor-Specific Antibodies With the Use of Luminex Single-Antigen Beads Is a Reliable Predictor of Acute Rejection in Living-Relative Kidney Recipients

Patients with de novo DSAs at high strength may suffer a high risk of developing an AR episode. Therefore, careful monitoring of de novo DSAs with the use of Luminex single-antigen beads may help in early intervention for AR in renal allografts and to minimize renal damage caused by the antibodies.